Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
Mvundura M, Frivold C, Janik Osborne A, Soni P, Robertson J, Kumar S, Anena J, Gueye A, Menozzi-Arnaud M, Giersing B, Kahn AL, Scarna T, Kristensen D. Mvundura M, et al. Among authors: menozzi arnaud m. Vaccine. 2021 Dec 3;39(49):7195-7207. doi: 10.1016/j.vaccine.2021.08.024. Epub 2021 Aug 16. Vaccine. 2021. PMID: 34412922 Free PMC article.
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
Giersing B, Shah N, Kristensen D, Amorij JP, Kahn AL, Gandrup-Marino K, Jarrahian C, Zehrung D, Menozzi-Arnaud M. Giersing B, et al. Among authors: menozzi arnaud m. Vaccine. 2021 Dec 3;39(49):7208-7219. doi: 10.1016/j.vaccine.2021.07.091. Epub 2021 Oct 7. Vaccine. 2021. PMID: 34627624 Free PMC article. Review.
How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making.
Botwright S, Kahn AL, Hutubessy R, Lydon P, Biey J, Karim Sidibe A, Diarra I, Nadjib M, Suwantika AA, Setiawan E, Archer R, Kristensen D, Menozzi-Arnaud M, Mpia Bwaka A, Mwenda JM, Giersing BK. Botwright S, et al. Among authors: menozzi arnaud m. Vaccine X. 2020 Oct 6;6:100078. doi: 10.1016/j.jvacx.2020.100078. eCollection 2020 Dec 11. Vaccine X. 2020. PMID: 33196036 Free PMC article.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Hasso-Agopsowicz M, Crowcroft N, Biellik R, Gregory CJ, Menozzi-Arnaud M, Amorij JP, Gilbert PA, Earle K, Frivold C, Jarrahian C, Mvundura M, Mistilis JJ, Durrheim DN, Giersing B. Hasso-Agopsowicz M, et al. Among authors: menozzi arnaud m. Front Public Health. 2022 Mar 2;10:809675. doi: 10.3389/fpubh.2022.809675. eCollection 2022. Front Public Health. 2022. PMID: 35309224 Free PMC article. Review.
Estimating the future global dose demand for measles-rubella microarray patches.
Ko M, Malvolti S, Cherian T, Mantel C, Biellik R, Jarrahian C, Menozzi-Arnaud M, Amorij JP, Christiansen H, Papania MJ, Meltzer MI, Masresha BG, Pastor D, Durrheim DN, Giersing B, Hasso-Agopsowicz M. Ko M, et al. Among authors: menozzi arnaud m. Front Public Health. 2023 Jan 16;10:1037157. doi: 10.3389/fpubh.2022.1037157. eCollection 2022. Front Public Health. 2023. PMID: 36726626 Free PMC article.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Scarnà T, Menozzi-Arnaud M, Friede M, DeMarco K, Plopper G, Hamer M, Chakrabarti A, Gilbert PA, Jarrahian C, Mistilis J, Hesselink R, Gandrup-Marino K, Amorij JP, Giersing B. Scarnà T, et al. Among authors: menozzi arnaud m. Expert Opin Drug Deliv. 2023 Mar;20(3):315-322. doi: 10.1080/17425247.2023.2168641. Epub 2023 Jan 27. Expert Opin Drug Deliv. 2023. PMID: 36649573